Abstract
The correct assessment of the activity of the pathological process in the CNS of MS patients has been impossible until now. All methods of scoring or ranking clinical findings in patients are hampered by the fact that an active and extensive demyelinating process may be present in a “silent” part of the CNS, and that small lesions may cause extensive signs and symptoms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Delpech B, Lichtblau E (1972) Etude quantitative des immunoglobulines G et de l’albumine du liquide céphalo-rachidien. Clin Chim Acta 37:15–23
Fog T (1964a) The long term treatment of multiple sclerosis with corticoids. Acta Neurol Scand [Suppl 13] 41:473–485
Fog T (1964b) A scoring system for neurological impairment in multiple sclerosis. Acta Neurol Scand [Suppl 13] 41:551–555
Ganrot K, Laurell CB (1974) Measurements of IgG and albumin content of cerebrospinal fluid and its interpretation. Clin Chem 20:571–573
HLA and disease. Multiple Sclerosis. In: Bodmer WF, Batchelor JR, Bodmer JG, Festenstein H, Morris PJ (eds) Histocompatibility testing 1977. Munksgaard, Copenhagen, pp 207–210
Hommes OR, Lamers KJB (1977) Immunosuppression in chronic progressive multiple sclerosis. In: Delmotte P, Hommes OR, Gonsette R (eds) Immunosuppression in chromic progressive multiple sclerosis. European Press, Gent, pp 48–65
Hommes OR, Prick JJG, Lamers KJB (1975) Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone. Clin Neurol Neurosurg 78:59–73
Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, Dupont B (1973) Histocompatibility determinents in multiple sclerosis with special reference to clinical course. Lancet 11:1221–1225
Lamers KJB, Hommes OR, Kok JCN (1977) Cerebrospinal fluid IgG in multiple sclerosis patients during and after intensive immunosuppressive treatment. In: Delmotte P, Hommes OR, Gonsette R (eds) Immunosuppressiv treatment in multiple sclerosis. European Press, Gent, pp 182–195
Schmidt R, Rieder HP, Wüthrich R (1977) The course of multiple sclerosis cases with extremely high γ-globulin values in cerebrospinal fluid. Eur Neurol 15:241–248
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hommes, O.R., Lamers, K.J.B., Reekers, P. (1980). Assessment of Process Activity in Multiple Sclerosis and Changes in Spinal Fluid. In: Bauer, H.J., Poser, S., Ritter, G. (eds) Progress in Multiple Sclerosis Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67554-6_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-67554-6_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67556-0
Online ISBN: 978-3-642-67554-6
eBook Packages: Springer Book Archive